Stem Cells
Therapies

Stem Cells Therapies

The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).

FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.

Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.

Check the full list of patients who received stem cell therapy derived from FamiCord labs.

List last update: 06.2026

List of patients who received stem cells from FamiCord Group laboratories

List of patients who received stem cells from FamiCord Group laboratories
Lp.	Source	Source type	Diagnosis	Medical field	Year of application	Therapy	Country	Age of recipient
8801	Apheresis	Autologous	Plasmacytoma	Hematology	2008	Standard Therapy	Germany	60
8802	Apheresis	Autologous	Plasmacytoma	Hematology	2008	Standard Therapy	Germany	67
8803	Apheresis	Autologous	Plasmacytoma	Hematology	2008	Standard Therapy	Germany	68
8804	Apheresis	Autologous	Plasmacytoma	Hematology	2008	Standard Therapy	Germany	57
8805	Apheresis	Autologous	Plasmacytoma	Hematology	2008	Standard Therapy	Germany	62
8806	Apheresis	Autologous	Plasmacytoma	Hematology	2008	Standard Therapy	Germany	63
8807	Apheresis	Autologous	Plasmacytoma	Hematology	2008	Standard Therapy	Germany	66
8808	Apheresis	Allogeneic	Refractory Acute Myeloid Leukemia	Hematology	2008	Standard Therapy	Germany	71
8809	Apheresis	Allogeneic	Secondary Acute Myeloid Leukemia	Hematology	2008	Standard Therapy	Germany	53
8810	Apheresis	Allogeneic	Secondary Acute Myeloid Leukemia	Hematology	2008	Standard Therapy	Germany	55
8811	Apheresis	Allogeneic	Secondary Acute Myeloid Leukemia	Hematology	2008	Standard Therapy	Germany	65
8812	Apheresis	Allogeneic	Severe Aplastic Anemia	Hematology	2008	Standard Therapy	Germany	29
8813	Apheresis	Allogeneic	T-Cell Lymphoblastic Leukemia	Hematology	2008	Standard Therapy	Germany	38
8814	Apheresis	Autologous	T-Cell Non-Hodgkin Lymphoma	Hematology	2008	Standard Therapy	Germany	28
8815	Apheresis	Autologous	T-Cell Non-Hodgkin Lymphoma Relapse	Hematology	2008	Standard Therapy	Germany	21
8816	Cord Blood	Allogeneic – Related	Neuroblastoma	Hematology	2007	Standard Therapy	Poland	8
8817	Cord Blood	Allogeneic – Related	SCID (Severe Combined Immunodeficiency)	Hematology	2007	Standard Therapy	Portugal	1
8818	Cord Blood	Allogeneic – Related	Thalassemia	Hematology	2007	Standard Therapy	UK	7
8819	Bone Marrow Family	Allogeneic	Acute Myeloid Leukemia	Hematology	2007	Standard Therapy	Germany	68
8820	Bone Marrow	Allogeneic	Paroxysmal Nocturnal Hemoglobinuria (PNH)	Hematology	2007	Standard Therapy	Germany	38
8821	Apheresis	Allogeneic	Aplastic Anemia	Hematology	2007	Standard Therapy	Germany	49
8822	Apheresis	Allogeneic	Chronic Lymphocytic Leukemia	Hematology	2007	Standard Therapy	Germany	57
8823	Apheresis	Autologous	Myocardial Infarction	Hematology	2007	Standard Therapy	Germany	61
8824	Apheresis	Autologous	Non-Hodgkin Lymphoma	Hematology	2007	Standard Therapy	Germany	57
8825	Cord Blood	Allogeneic – Related	Aplastic Anemia	Hematology	2005	Standard Therapy	Germany	5
8826	Cord Blood	Autologous	Brain Damage	Neurology	2005	Experimental Therapy	Germany	1
8827	Cord Blood	Allogeneic – Related	Leukemia	Hematology	2005	Standard Therapy	UK	0
8828	Cord Blood	Allogeneic – Related	Thalassemia	Hematology	2005	Standard Therapy	UK	4
8829	Cord Blood	Autologous	Acute Lymphoblastic Leukemia	Hematology	2004	Standard Therapy	Germany	3

Page 89 from 89 1 87 88 89